Page last updated: 2024-10-24

adrenomedullin receptor activity

Definition

Target type: molecularfunction

Combining with adrenomedullin to initiate a change in cell activity. [GOC:ai]

Adrenomedullin receptor activity is a molecular function associated with the transmembrane receptor that binds adrenomedullin, a potent vasodilator and hypotensive peptide. This receptor, also known as the calcitonin receptor-like receptor (CLR), belongs to the class B G protein-coupled receptors (GPCRs). Upon binding of adrenomedullin, the receptor activates downstream signaling pathways, primarily involving the G protein Gs, leading to the production of cAMP and the activation of protein kinase A (PKA). This signaling cascade results in a multitude of physiological effects, including:

* **Vasodilation:** Adrenomedullin receptor activation leads to relaxation of vascular smooth muscle, causing vasodilation and lowering blood pressure.
* **Cardioprotection:** Adrenomedullin plays a protective role in the heart, reducing myocardial damage and inflammation.
* **Anti-inflammatory effects:** Adrenomedullin receptor activation inhibits the production of pro-inflammatory cytokines, contributing to its overall anti-inflammatory properties.
* **Regulation of fluid balance:** Adrenomedullin receptor signaling affects renal function, influencing sodium and water excretion.
* **Regulation of cell growth and differentiation:** Adrenomedullin receptor activation influences cell proliferation and differentiation in various tissues.

The adrenomedullin receptor is expressed in a wide range of tissues and organs, including the cardiovascular system, kidneys, lungs, brain, and gastrointestinal tract. Its diverse functions highlight its significant role in maintaining physiological homeostasis and regulating various physiological processes.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Calcitonin gene-related peptide type 1 receptorA calcitonin gene-related peptide type 1 receptor that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q16602]Homo sapiens (human)
Receptor activity-modifying protein 3A receptor activity-modifying protein 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60896]Homo sapiens (human)
Receptor activity-modifying protein 2A receptor activity-modifying protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O60895]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
haloperidolhaloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
azaperoneazaperone : An N-arylpiperazine that is 2-(piperazin-1-yl)pyridine in which the amino hydrogen is replaced by a 3-(4-fluobenzoyl)propyl group. Used mainly as a tranquiliser for pigs and elephants.

Azaperone: A butyrophenone used in the treatment of PSYCHOSES.
aminopyridine;
aromatic ketone;
monofluorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
tertiary amino compound
antipsychotic agent;
dopaminergic antagonist
telcagepanttelcagepant: structure in first source
mk 3207
bms 694153
(5s,6s,9r)-5-amino-6-(2,3-difluorophenyl)-6,7,8,9-tetrahydro-5h-cyclohepta(b)pyridin-9-yl 4-(2-oxo-2,3-dihydro-1h-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxylate
mk-8825
atogepantatogepant : A secondary carboxamide resulting from the formal condensation of the carboxy group of (3'S)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxylic acid with the amino group of (3S,5S,6R)-3-amino-6-methyl-1-(2,2,2-trifluoroethyl)-5-(2,3,6-trifluorophenyl)piperidin-2-one. It is a selective oral, small-molecule antagonist of calcitonin gene-related peptide (CGRP) receptor that has been approved for the treatment of migraine.azaspiro compound;
organic heterotetracyclic compound;
piperidones;
secondary carboxamide;
trifluorobenzene
calcitonin gene-related peptide receptor antagonist